Skip to content
Search

Latest Stories

NHS to roll out same-day pre-eclampsia test for pregnant women

The NHS is going to roll out a same-day life-saving test for pregnant women to rule out pre-eclampsia – a life-threatening condition.

Known as placental growth factor (PLGF) testing, the new blood test is the first of its kind in the world and has already helped thousands of expectant mothers with quick diagnosis.


It will significantly reduce the need for hospital trips, freeing up clinics and staff workload, as nearly 65,000 pregnant women are admitted to hospital every year for up to three days to be monitored for the condition.

The new testing is being rolled out as part of the NHS Long Term Plan’s aim to invest in more ‘world-class’ treatments and cutting-edge technologies.

Currently, three-quarters of maternity units are using the test, and it will be available across all of England within the next two years.

NHS director of innovation, research and life sciences Matt Whitty said: “This test is quick and easy and can rule out a condition that has for a long time been the of cause such stress to tens of thousands of pregnant women every year, whether they have pre-eclampsia or not.

“This latest innovation will benefit thousands of patients who have until now been put through extensive testing and possible hospital stays as the NHS continues to deliver on ambitious Long Term Plan commitments to provide patients with the most up to date tech, as quickly as possible.”

Women experiencing symptoms, such as high blood pressure and headaches, which usually occur in the second half of pregnancy, will be advised by their GP or midwife to go for the test as part of a full clinical assessment.

Treatments involve medication for high blood pressure or in extreme cases, anticonvulsants to prevent fits if the baby is due.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less